Atezolizumab

Tecentriq (atezolizumab) is a prescription monoclonal antibody made by Genentech, Inc., given intravenously to treat certain cancers. It works by blocking PD-1 receptors to help the immune system fight tumors. Available as a 1200 mg/20 mL solution in single-use vials. This information was generated using AI and is provided for informational and research purposes only.